IP Library › Assignment 050017/0421
Patent Assignment
Reel/Frame 050017/0421

Assignment of Assignor's Interest

Recorded: 2019-08-09 Pages: 5
Assignor
CRISPR THERAPEUTICS AG
Executed: 2019-07-24
Assignee
VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE, BOSTON, MASSACHUSETTS, 02210
Covered Properties (2)
Materials and Methods for Treatment of Duchenne Muscular Dystrophy
Application: 15/763,328 →
Publication: US 2019/0374655
Materials and Methods for Treatment of Myotonic Dystrophy Type 1 (DM1) and Other Related Disorders
Application: 16/312,651 →
Publication: US 2019/0211362
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 12, 2019
From: LUNDBERG, ANTE SVEN; KULKARNI, SAMARTH; KLEIN, LAWRENCE; PADMANABHAN, HARI KUMAR
To: CRISPR THERAPEUTICS AG
Reel/Frame 048309/0936 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 050017 Frame: 0421. Assignor(S) Hereby Confirms the Assignment. Mar 10, 2021
From: CRISPR THERAPEUTICS AG
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 055548/0188 →